Last reviewed · How we verify

NCT05748912: FOCUS

Lung Function Outcomes Following Removal of Airway Mucus Plugs in Patients With Asthma (FOCUS)

Withdrawn NA Last updated 13 January 2026
What this trial tests

NA trial testing Therapeutic bronchoscopy for removal of mucus plugs in Asthma. Withdrawn.

Timeline
26 January 2022
Primary endpoint
25 March 2025
25 March 2025

Quick facts

Lead sponsorUniversity of California, San Francisco
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Start date26 January 2022
Primary completion25 March 2025
Estimated completion25 March 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of California, San Francisco

Who can join

Adults 18 to 80, any sex, with Asthma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a single-center study that will evaluate the safety and tolerability of removal of mucus plugs by bronchoscopy in patients with asthma. This protocol will also plan for the analysis of the features of the mucus plugs removed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Asthma

Currently open trials in the same condition.

Other University of California, San Francisco trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05748912.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing